blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0550507

EP0550507 - INDOLE UREAS AS 5 HT RECEPTOR ANTAGONIST [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  11.10.1996
Database last updated on 05.10.2024
Most recent event   Tooltip11.10.1996Application deemed to be withdrawnpublished on 27.11.1996 [1996/48]
Applicant(s)For all designated states
Beecham Group p.l.c.
SB House, Great West Road Brentford
Middlesex TW8 9BD / GB
[N/P]
Former [1993/28]For all designated states
Beecham Group p.l.c.
SB House Great West Road
Brentford Middlesex TW8 9BD / GB
Inventor(s)01 / FORBES, Ian Thomson
SmithKline Beecham Pharm., Coldharbour Road
The Pinnacles, Harlow, Essex CM19 5AD / GB
02 / MARTIN, Roger Thomas
SmithKline Beecham Pharm., Coldharbour Road
The Pinnacles, Harlow, Essex CM19 5AD / GB
[1993/28]
Representative(s)Giddings, Peter John
GlaxoSmithKline
Global Patents (CN925.1)
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
[N/P]
Former [1993/30]Giddings, Peter John, Dr.
SmithKline Beecham plc Corporate Intellectual Property SB House Great West Road
Brentford, Middlesex TW8 9BD / GB
Application number, filing date91916525.811.09.1991
[1993/28]
WO1991GB01553
Priority number, dateGB1990002003013.09.1990         Original published format: GB 9020030
GB1991000607922.03.1991         Original published format: GB 9106079
GB1991000609222.03.1991         Original published format: GB 9106092
GB1991000609422.03.1991         Original published format: GB 9106094
[1993/28]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9205170
Date:02.04.1992
Language:EN
[1992/08]
Type: A1 Application with search report 
No.:EP0550507
Date:14.07.1993
Language:EN
The application published by WIPO in one of the EPO official languages on 02.04.1992 takes the place of the publication of the European patent application.
[1993/28]
Search report(s)International search report - published on:EP02.04.1992
ClassificationIPC:C07D401/12, A61K31/44
[1993/28]
CPC:
C07D213/75 (EP,US); C07D401/12 (EP,KR,US); A61P25/20 (EP);
A61P43/00 (EP)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   SE [1993/28]
TitleGerman:INDOLHARNSTOFFE ALS 5HT REZEPTOR-ANTAGONIST[1993/28]
English:INDOLE UREAS AS 5 HT RECEPTOR ANTAGONIST[1993/28]
French:UREES D'INDOLE UTILISEES COMME ANTAGONISTES DE RECEPTEUR DE 5-HT[1993/28]
File destroyed:20.04.2002
Entry into regional phase09.03.1993National basic fee paid 
09.03.1993Designation fee(s) paid 
09.03.1993Examination fee paid 
Examination procedure02.03.1992Request for preliminary examination filed
International Preliminary Examining Authority: DE
09.03.1993Examination requested  [1993/28]
22.12.1995Despatch of a communication from the examining division (Time limit: M04)
03.05.1996Application deemed to be withdrawn, date of legal effect  [1996/48]
28.06.1996Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [1996/48]
Fees paidRenewal fee
16.09.1993Renewal fee patent year 03
12.09.1994Renewal fee patent year 04
06.09.1995Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]  - JOURNAL OF MEDICINAL CHEMISTRY. vol. 29, no. 11, November 1986, WASHINGTON US pages 2415 - 2418; P. FLUDZINSKI: '2,3-dialkyl(dimethylamino)indoles:Interaction with 5HT1, 5HT2 and rat stomach fundal serotin receptors.' cited in the application see the whole document SA 51152 030
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.